|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 453/00 | |
| A61K 31/4427 | |||
| A61P 11/06 |
| (11) | Patento numeris | 3152202 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14730808.4 |
| Europos patento paraiškos padavimo data | 2014-06-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-11-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/061604 |
| Data | 2014-06-04 |
| (87) | Numeris | WO 2015/185130 |
| Data | 2015-12-10 |
| (72) |
AMARI, Gabriele, IT
ARMANI, Elisabetta, IT
RICCABONI, Mauro, IT
RIZZI, Andrea, IT
BAKER-GLENN, Charles, IT
BLACKABY, Wesley, IT
VAN DE PO L, Hervé, IT
WHITTAKER, Ben, IT
|
| (73) |
Chiesi Farmaceutici S.p.A.,
Via Palermo, 26/A, 43100 Parma,
IT
|
| (54) | 3,5-DICHLORO,4-(3,4-(CYCLO-)ALKOXYPHENYL)--2-CARBONYLOXY)ETHYL)PYRIDINE DERIVATIVES AS PDE-4 INHIBITORS AND MUSCARINIC M3 RECEPTOR ANTAGONISTS |
| 3,5-DICHLORO,4-(3,4-(CYCLO-)ALKOXYPHENYL)--2-CARBONYLOXY)ETHYL)PYRIDINE DERIVATIVES AS PDE-4 INHIBITORS AND MUSCARINIC M3 RECEPTOR ANTAGONISTS |